A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies.
about
Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.Characterization of fluorescent chimeras of cholera toxin and Escherichia coli heat-labile enterotoxins produced by use of the twin arginine translocation systemNontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activationSecretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccineA bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity.Polymyxins as novel and safe mucosal adjuvants to induce humoral immune responses in mice.Oral and nasal sensitization promote distinct immune responses and lung reactivity in a mouse model of peanut allergy.Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infectionA second generation of double mutant cholera toxin adjuvants: enhanced immunity without intracellular trafficking.Nasal Administration of Cholera Toxin as a Mucosal Adjuvant Damages the Olfactory System in Mice.Progress toward development of an inhalation vaccine against botulinum toxin.Sublingual vaccination with influenza virus protects mice against lethal viral infection.Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies.Mucosal vaccine development for botulinum intoxication.A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migrationA combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity.Mucosal vaccines: novel advances in technology and delivery.Bioadhesive delivery systems for mucosal vaccine delivery.Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract.Immunogenicity of a Staphylococcus aureus-cholera toxin A2/B vaccine for bovine mastitis.
P2860
Q33715999-0E03EC5F-7DC4-4EED-8A9A-3D2C8DB1488EQ33788186-DE7AC5CC-5CCD-49D9-84A0-D62B674A1347Q33883311-A70F6C1B-06FD-42A2-9E0E-451CFD5B3E2EQ33928456-835DC16F-4E50-4EBB-9DD8-1236C74998D0Q34301259-CC6B8D85-F18C-41F2-8D27-1AC0F29F70ABQ34675017-6A3C071E-483E-4429-84CB-31F43A9D5B94Q35094515-F04BC61D-A6CA-41EC-A550-114DE9F8E31DQ35550138-A798E2C8-DFE9-4777-A9B5-9F9527F92B74Q35747402-F5068D41-1F04-472D-BA47-6406B3546C27Q35793731-716AF94F-01C6-4469-B967-D363372E0FFCQ35843653-954B207D-8307-4876-A9C6-621D22CA655EQ36446440-776C1E3A-C248-4113-804C-FDB612AE450EQ36710668-D7B5F0F3-4BEB-4FCC-8767-782B270CAD3CQ36728788-F72A5BA4-B980-44CD-9E10-874FF51F3D64Q36983731-73FDD4A8-30B5-466B-A1E4-C3821E50F2DAQ37012511-F8416C42-F159-48C2-860D-A5ADC1B4F2A0Q37559647-1D55F3E6-D270-48BF-908A-C15AD38AD4B4Q37805519-E43922BB-665A-4EFB-BF23-FC72CE8D74E0Q38320741-8768C58C-0FC9-4CB6-B119-A341FFCD49BEQ54217815-26C68926-3A02-4E5D-9339-DD311D525359
P2860
A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A nontoxic chimeric enterotoxi ...... s with reduced IgE antibodies.
@ast
A nontoxic chimeric enterotoxi ...... s with reduced IgE antibodies.
@en
A nontoxic chimeric enterotoxi ...... s with reduced IgE antibodies.
@nl
type
label
A nontoxic chimeric enterotoxi ...... s with reduced IgE antibodies.
@ast
A nontoxic chimeric enterotoxi ...... s with reduced IgE antibodies.
@en
A nontoxic chimeric enterotoxi ...... s with reduced IgE antibodies.
@nl
prefLabel
A nontoxic chimeric enterotoxi ...... s with reduced IgE antibodies.
@ast
A nontoxic chimeric enterotoxi ...... s with reduced IgE antibodies.
@en
A nontoxic chimeric enterotoxi ...... s with reduced IgE antibodies.
@nl
P2093
P356
P1476
A nontoxic chimeric enterotoxi ...... ts with reduced IgE antibodies
@en
P2093
Akira Miyauchi
Frederik W Van Ginkel
Fumiko Watanabe
Hiroaki Takagi
Hiroshi Kiyono
Jerry R McGhee
Kohtaro Fujihashi
Masafumi Yamamoto
Mi-Na Kweon
Shinichi Tamura
P304
P356
10.1086/344526
P407
P50
P577
2002-10-03T00:00:00Z